Delivery Order SPE2DB22D2206-SPE2DB25FJC68
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $24,506.55 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a competitive, firm fixed-price award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal disease,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) valued at $6,760.81 under a firm fixed-price arrangement. This non-set-aside delivery order was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease and...
- The Defense Logistics Agency awarded a delivery order valued at $194,207.50 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5ml) under a firm fixed price contract. The award, issued on July 31, 2025, with completion scheduled for August 1, 2025, represents a direct procurement of this pneumococcal vaccine product to be performed at the vendor's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $14,078.16 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on July 30, 2025, with a completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease across multiple age groups, making it...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) valued at $22,721.30 under a firm fixed-price contract. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization programs within military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $21,259.16 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5mL syringes. This non-set-aside, firm fixed price delivery order was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Prevnar 20 is a pneumococcal conjugate vaccine used across military and federal healthcare systems to protect against...
- The Defense Logistics Agency awarded a delivery order valued at $7,010.33 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe form (0.5ML) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $9,187.28 delivery order to AmerisourceBergen Drug Corp for Prevnar 20 syringes (0.5 mL) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's facility...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,337.70 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 vaccine in 0.5ML syringes. This non-competitive delivery order was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, and is priced on a firm fixed price basis. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $27,844.80 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJC68Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,274.97 to AmerisourceBergen Drug Corp for PREVNAR 20 Syringe 0.5ML, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease, supporting the federal government's medical supply requirements for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor, the company supplies a comprehensive portfolio of medications and medical supplies to support military healthcare programs globally, including vaccines, specialty medications, and medical commodities across multiple therapeutic areas. The DLA Troop Support is currently planning for next-generation Pharmaceutical Prime Vendor Global Program contracts with anticipated multiple awards across separate regions, positioning AmerisourceBergen as a key strategic supplier for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 7/28/25 |